Delivery Order SPE2DB20D2104-SPE2DB24FT01W
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM capsules. The contract has a ceiling value of $11,059.33 and an ultimate completion date of April 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $1,335.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Vascepa 1 GM capsules, a cardiovascular medication, with a ceiling value of $1,732.01. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.49 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $3,436.32 firm-fixed-price delivery order for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $32,821.65 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of VASCEPA 1 GM CAPSULE 120S. This contract has a completion date of May 4, 2023 and uses a firm fixed price pricing type. The award was made without any set-aside designations, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $15,047.32 delivery order contract is for the supply of VASCEPA 1 GM capsules, a cardiovascular medication. The contract is a firm fixed-price, Delivery Order type with an ultimate completion date of October 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,023.88, is a delivery order for the supply of the medication Vascepa 1 GM Capsule 120S. The contract has a firm fixed price and an ultimate completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. The $1,919.46 Firm Fixed Price delivery order has an ultimate completion date of October 23, 2023. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products to various government agencies, particularly supporting military and veterans'...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT01WDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,539.45, is for the delivery of Vascepa 1 GM capsules. It is a firm-fixed price delivery order contract with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in pharmaceutical distribution and medical supply procurement for federal agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 3/12/24 |